BetaStem Therapeutics, Inc. , a pre-clinical biotechnology company focused on a curative treatment for diabetic retinopathy and diseases related to vascular damage , has retained Conditas Biotechnology Group, LLC for its services in the area of business development and corporate strategy.
http://www.businesswire.com/news/topix/20130718005041/en
http://www.businesswire.com/news/topix/20130718005041/en
No comments:
Post a Comment